JEFFREY D. WHITE, M.D., DIRECTOR

Jeffrey D. White, M.D., joined NCI in 1990 as a Medical Staff Fellow in the Metabolism Branch where he performed laboratory research in immunology and molecular biology. While in the Metabolism Branch, he served in various positions culminating as director of the Clinical Trials and Clinical Care Program. In that capacity, he coordinated the development and administration of phase I and II clinical trials using unmodified and radiolabeled monoclonal antibody constructs. Dr. White has been principal investigator for and has reported the results from trials of various experimental treatments for patients with adult T-cell leukemia/lymphoma (ATL) and cutaneous T-cell lymphoma (CTCL).

From 1995 to 1998, Dr. White also served as an oncology consultant to the director of the NIH’s Office of Alternative Medicine. In October 1998, he was chosen to serve as director of a new office in the NCI titled the Office of Cancer Complementary and Alternative Medicine (OCCAM). The office was created to augment the activities of the different divisions at NCI that were already supporting CAM research. OCCAM continues to promote and support research and generation of good quality information on the various disciplines and modalities associated with the field of complementary and alternative medicine (CAM) as they relate to the diagnosis, prevention and treatment of cancer.

Dr. White is a board certified medical oncologist and a cancer researcher. Dr. White graduated from Cornell University with a B.S. in Applied and Engineering Physics in 1979 and received an M.D. from Howard University in 1984. He completed a residency in internal medicine in 1987 and fellowships in oncology and hematology in 1990 at The Washington Hospital Center in Washington, D.C.